Krause Sabine, Rennen Huub J, Boerman Otto C, Baumann Sabine, Cyr John E, Manchanda Rajesh, Lister-James John, Corstens Frans C, Dinkelborg Ludger M
Bayer Schering Pharma AG, Global Drug Discovery, D-13342 Berlin, Germany.
Nucl Med Biol. 2007 Nov;34(8):925-32. doi: 10.1016/j.nucmedbio.2007.07.016.
The technetium 99 m (99mTc)-radiolabeled, leukocyte-avid peptide-glycoseaminoglycan complex, [99mTc]P1827DS, has been synthesized as an improved infection/inflammation imaging agent to [99mTc]P483H (LeukoTect, Diatide). In a phase I/II clinical trail, [99mTc]P483H images were equivalent to those obtained with 111In ex vivo labeled leukocytes. However, there was physiologic accumulation of radioactivity in the body that could hamper interpretation of the images. In this study, the potential of [99mTc]P1827DS for infection imaging was assessed in comparison with [99mTc]P483H and the well-described imaging agent [99mTc] hydrazinonicotinamide (HYNIC)-interleukin 8 (IL-8).
The binding of [99mTc]P1827DS to human blood cell was studied in vitro. A rabbit Escherichia coli infection model was used to perform the biodistribution and imaging studies with [99mTc]P1827DS, [99mTc]P483H and [99mTc]HYNIC-IL-8.
[99mTc]P1827DS binds to leukocytes but not to erythrocytes. The leukocyte binding was not saturable up to an investigated concentration of 10 microM. The accumulation of [99mTc]P1827/DS at the infection site strongly depends on the P1827/DS ratio and was optimal at a molar ratio of 10:1. [99mTc]P1827DS shows improved biodistribution over [99mTc]P483H with similar uptake at the infection site. Abscess uptake of [99mTc]HYNIC-IL-8 was approximately three times higher than that of [99mTc]P1827DS. [99mTc]HYNIC-IL-8 showed high accumulation in the kidneys, whereas [99mTc]P1827DS showed high lung uptake and slightly higher accumulation in the liver and spleen.
[99mTc]P1827DS is a potential new inflammation imaging agent, which clearly visualized the abscess in the rabbit E. coli infection model and showed improved biodistribution compared to [99mTc]P483H. However, the infection uptake and biodistribution of [99mTc]P1827DS is not superior to that of [99mTc]HYNIC-IL-8 in this animal model.
已合成锝99m(99mTc)放射性标记的、白细胞亲和性肽-葡萄糖胺聚糖复合物[99mTc]P1827DS,作为一种比[99mTc]P483H(LeukoTect,Diatide)更好的感染/炎症显像剂。在一项I/II期临床试验中,[99mTc]P483H的图像与用111In体外标记白细胞获得的图像相当。然而,体内存在放射性的生理性蓄积,这可能会妨碍图像的解读。在本研究中,将[99mTc]P1827DS与[99mTc]P483H以及已得到充分描述的显像剂[99mTc]肼基烟酰胺(HYNIC)-白细胞介素8(IL-8)进行比较,评估了[99mTc]P1827DS用于感染显像的潜力。
在体外研究了[99mTc]P1827DS与人血细胞的结合。使用兔大肠杆菌感染模型对[99mTc]P1827DS、[99mTc]P483H和[99mTc]HYNIC-IL-8进行生物分布和显像研究。
[99mTc]P1827DS与白细胞结合,但不与红细胞结合。在所研究的浓度高达10微摩尔时,白细胞结合不饱和。[99mTc]P1827/DS在感染部位的蓄积强烈依赖于P1827/DS的比例,在摩尔比为10:1时最佳。与[99mTc]P483H相比,[99mTc]P1827DS显示出更好的生物分布,在感染部位的摄取相似。[99mTc]HYNIC-IL-8在脓肿部位的摄取比[99mTc]P1827DS高约三倍。[99mTc]HYNIC-IL-8在肾脏中显示出高蓄积,而[99mTc]P1827DS在肺部摄取高,在肝脏和脾脏中的蓄积略高。
[99mTc]P1827DS是一种潜在的新型炎症显像剂,在兔大肠杆菌感染模型中能清晰显示脓肿,与[99mTc]P483H相比生物分布有所改善。然而,在该动物模型中,[99mTc]P1827DS的感染部位摄取和生物分布并不优于[99mTc]HYNIC-IL-8。